Heading into its 27th edition in 2017, In-cosmetics Global is the leading event for personal care ingredients. The exhibition brings together personal care ingredients suppliers (exhibitors) with finished product manufacturers (visitors) looking to network, learn about future trends and discover new products.
The popularity and success of the event continues to grow year on year. The most recent show attracted a record number of visitors (9,668), an increase of 13% on 2016.
In-cosmetics Global continues to attract visitors worldwide who are looking to find new ingredients and innovations from the international suppliers that don’t appear at other shows. In 2016 we welcomed 63% of international visitors from 121 countries.
These industry professionals came to see the 792 personal care suppliers of ingredients, fragrances, lab equipment, testing and regulatory solutions. The best represented nations amongst exhibitors were France (220 exhibitors) and Germany (91), followed by China (67), USA (53) and Italy (52).
In-cosmetics Global brings together 700+ exhibitors of ingredients, fragrances, lab equipment, testing and regulatory solutions with over 9,000 cosmetic manufacturers worldwide. The leading exhibition in personal care formulation, in-cosmetics shapes future global industry trends and offers the most cost-effective business and networking opportunities for the personal care ingredient community.
The global launchpad for innovations in ingredients and technologies, in-cosmetics delivers a world-class and highly interactive educational programme for formulators, R&D and regulatory professionals. in-cosmetics 2016 was the biggest show to date – don’t miss in-cosmetics 2017.
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Anti-aging magic medicine! Hydrangea leaf extract improves skin
Global chemical output decline narrows, China contributes the most
Scientists alarm: sugar causes wrinkles!
High-dose vitamin D supplementation has no current benefit in preventing
UK trials remdesivir treatment for COVID-19 as UK PM aide row rages on
Poland’s Salmonella poultry problem continues